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I. Introduction:- A study of the pharmacological properties 
of S-oxysantonin and the sulfate of santoninamine has 
been undertaken, not only to extend our knowledge of 
these compounds, hut to compare their properties with those 
of the parent substance, santonin.
I-A* Review of Literature:-
1. Chemical.
1 , 2Santonin is obtained from the unexpanded 
flowej£heads of Artemisia pauciflora, Artemisia Cina, 
and Artemisia maritima. It crystallizes in colorless 
platelets which have a melting point of 170°. It is 
soluble in alcohol, benzene, and solutions of alkalies* 
but almost insoluble in water. The yellow photosantonin 
is formed on exposure of the crystals to light.
Various graphical formulae have been assigned
to santonin, the most important of which, until recently,
*5 Awas that of Cannizzaro . Clemo, Haworth, and Walton




Clemo^ has also isolated a/(f-santonin, a stereo-
isomeride of santonin. It occurs as colorless prisms which
melt between 216° and 218° and have an of -157.2°
oat 19 .
Five oxides of santonin which have the constitutional 
formula of C1 5H1 0 O4 have heen described in the literature#
c.
d i-oxysantonin was isolated by Jaffe from the urine 
of large meat-fed dogs which had received capsules containing 
one to two grams of santonin daily# The pure compound was 
difficultly. soluble in boiling alcohol, difficulty soluble in 
chloroform and almost insoluble in ether. It was partly 
soluble in water on long heating but separated out on cooling# 
The apueous solution was neutral in reaction. The product 
was easily soluble in hot glacial acetic acid but very diffi­
culty soluble in the cold acid. Solutions of the salts 
which were formed on long heating with dilute alkalies or 
alkaline earths remained clear at first on addition of acids 
but the anhydride gradually separated out. The colorless 
needle-like crystals of e«-oxysantonin melted with decomposition 
between 280° and 286° and had an £?'f̂ pOf -115° in alcohol.




<<5-oxysantonin was obtained by Jaffe from the ether
extract of the urine of rabbits which had been fed santonin*
This substance was easily soluble in cold alcohol, ether,
chloroform, and in hot water, but insoluble in petroleum ether
and difficulty soluble in cold water* It crystallized in
yellow platelets or leaves, was laevorotary, and melted to an
oily droplet between 128° and 130°.
"/-oxysantonin or artemisin was isolated by Merck
from the seeds of Artemesia maritima. It was soluble in hot
water and alkali solutions* The compound had C e Q ^o t -84.3°
and crystallized in massive needles or prisms which melted at 
o200 * The structure of artemisin has been studied by Freund and
9Mai • They obtained an oily product on distillation of 
artemisin in a stream of hydrogen which yielded dimethyl naph­
thalene1  ̂ on fractional distillation over sodium* This derivi-
tive had a boiling point of 264° and formed a picrate which 
omelted at 119 • The 1, 4-dimethylnapbbhalene obtained by
Cannizzaro and Carnelutti1'*' on reduction of santonin formed a
opicrate which melted at 139 * The more recent and more exact
12chemical research of Wedekind has proved the following 
graphical formula for artemisin to be correct:
CM
ARTEMISIN
Two oxysantonins have been prepared synthetically
by Wedekind and his co-workers* These were termed
1S 148 -oxysantonin or isoartemisin (later called oxysantonin )
15and (6 -oxysantonin
Wedekind and Tettweiler obtained a chlorhydrin by
the action of chlorine water on finely powdered santonin*
The product was boiled thoroughly with benzene to remove
unattacked santonin. The chlorhydrin which separated out
on cooling was reerystallized from dilute alcohol. It was
then converted into S-oxysantonin by the action of potassium
o ohydroxide in methyl alcohol between 50 and 60 • The long 
colorless needle-like crystals which were obtained on 
repeated reerystallization from boiling absolute alcohol 
had a melting point of 214 and an of -108.6°. It
was difficultly soluble in water and alkali solutions but 
easily soluble in chloroform.




A mixture of and oxysantonin was obtained by the 
action of perbenzoic acid on santonin in boiling chloroform.
-4-
($~oxysantonin, a spatial isomer of <tf-oxysantonin, 
was separated by difference of solubility in alcohol. It
by the use of 5 parts of santonin (1 mol.), 4 parts of
hydroxylamine hydrochloride ( 2  mols*), and 3-4 parts of
precipitated calcium carbonate suspended in 50 parts of
90$ alcohol. The mixture was heated for 3-4 days on a
water bath, the temperature of which was maintained between 
o o75-80 • The suspended matter was then filtered out and
the filtrate was added to 4-5 volumes of boiling hot water*
The lacy, silky white product which was obtained was purified
by reerystallization from cold alcohol. It melted between 
o o216 -217 . The following graphical formula was assigned 
to the oxime:
crystallized in colorless leaves and melted at 157 o
Santoninoxime was first prepared by Grucei16
SAMOIINOXIME
The sulfate of santoninamine was prepared from
17the oxime by Gucci and Grassi-Crislaldi . About 400 c.c. 
of 90fo alcohol were added to 10 gm. of the oxime. Then 
2 0 c.c. of concentrated sulfuric acid and 60 gm. of powdered 
zinc were added a little at a time. The mixture was shaken 
frequently and the temperature was not allowed to exceed 
30°-40°. Several drops of 10% platinum chloride were added 
to facilitate reduction.
After the reaction was complete, the remaining 
zinc was filtered from the alcoholic solution. Finally the 
alcohol was removed by distilling under reduced pressure#
A light yellow mass which was suspended in a very acid 
liquid remained. The amine was extracted from this mass 
by repeatedly dissolving in absolute alcohol and precipitating 
with 3-4 volumes of anhydrous ether. Isolation of the amine 
is rendered difficult due to its extreme solubility in water#
The purified product melted between-146°,and 146°, had a specific 
rotation ( ) of -103.67° and the constitutional formula
of O1 5H2 1NO2 .HgS04#Hg0. The following graphical formula 







Santonin has been used as a remedy against
16round worms since ancient times , for which purpose 
it is still considered a very valuable drug. It 
is reputed to have been used by the Russian peasants
as a folk-remedy for diabetes* It also acts as a
19 2 0 ,2 1 , 2 2  peripheral vasodilator , a diuretic , and
23 24increases uric acid elimination * * In toxic
dosages it produces violent gastro-intestinal irri­
tation, hematuria, xanthopsia, muscular weakness,
25 26 27convulsions, and fall of body temperature * * •
A more detailed review of the literature on santonin 
will be given under the various sections of the 
experimental part*
28Trendelenburg has reported that both 
S-oxysantonin and Y-oxysantonin had a strong action 
on the earthworm muscle preparation, as might be 
expected from their lactone character* The 5-oxy­
santonin was found to be only a little weaker than 
santonin when isomolecular solutions were used. The 
convulsant action of isoartemisin on the mouse was 
shown to be very much weaker than that of santonin.
The fatal dose is above 22 mgm. The effect of both 
oxysantonins on the heart was somewhat weaker than 
that of santonin when used in equivalent concentra-
-7-
tion (1:5000)* A 1:500 solution of artemisin, however, 
was very toxic, causing diastolic arrest in a few seconds*
29Coppola recommended that santoninoxime be 
used in treatment of ascaridiasis rather than satonin 
because of its lower toxicity. Schmidt*^ injected
0.05 to 0.2 gm* of the oxime and of the amine intravenously 
in rabbits and observed no toxic effects except with one 
rabbit. This animal died 6 hours after injection of 0.2 
gm. of the aminocompound. Weak convulsions were observed 
in this case. Lo Monoeo*' observed that the sulfate of 
santoninamine and soda were as effective as santonin and
soda. The effect of administration of the sulfate of
santoninamine on blood-sugar level has not been previously 
reported*
I-B. Scope of Problem.
The object of this research is to determine certain of 
the pharmacological properties of (a) 5-oxysantonin, 
namely: •
1. Anthelmintic Activity.
2. Influence on Cardiac Kate, Amplitude of 
contraction, and Output*
5. effect on Peripheral Circulation.
4. Ability to Act as a Diuretic.
5. Ability to Lower the Blood-Sugar Level.
a. Of Fasted Animals.
b. Of Animals which had Keceived Dextrose.
6 * Toxicity and Pathological Effects 
Produced on Liver and Kidney.
7. Excretion and Pate*
B. The Sulfate of Santoninamine;
1* Ability to lower the Blood-Sugar 
Level of Pasted Animals#
2. Pathological Effects Produced 
on Liver and Kidney.
II Experimental:-
1 . Anthelmintic Activity.
The anthelmintic activity of 6 -oxysantonin
was determined on earthworms, according to the
32method employed by Sollman • Five earthworms, 
each about 1 0 cm* long, were placed in 1 0 0 cc. of the 
solution to be tested. The control solution con­
tained 1 io of sodium bicarbonate and 0.04$ of bile 
salts in order to approximate the alkalinity of 
the pancreatic and intestinal juices and the solvent 
activity of the bile. The drug stock solution was 
a suspension of O .lfo of finely divided ^-oxysantonin 
in the control solution. The isoartemisin was 
only completely soluble in the lower dilutions*
Observations of the activity and appearance 
of the earthworms were made at the end of 3, 3, and 
1 0 hours in the case of the control solutions, and
- 9 -
within a minute and after 2 , 5, and 1 0 hours 
when the drug was employed. In order to make 
the final observations, each worm was lifted out 
by means of a hook from the beaker containing it 
and placed on a towel. The movements recorded 
in tables I and II were either spontaneous or 
the response to mechanical ( (pM), galvanic ( PG) , 
or weak faradic stimulation There was an
almost immediate appearance of a web-like pre­
cipitated secretion around the worms which were 
placed in the higher concentrations of the iso­
artemisin. This was followed in several hours 
by liquifaction of the external musculature which 
was especially marked in the 0 .1 % $-oxysantonin 
suspension, leading to rupture of many of the 
worms. Little secretion and no liquifaction were 
observed with the control worms#
The fatal concentration of S -oxysantonin 
was found to be between 0.0333% and 0,0666%, which 
placed the drug in uroup III of Sollmann's classi­
fication. Hence, it may be regarded as a rather
32weak vermicide as compared with santonin , the 
fatal concentration of which is 0.001% to 0.009%. 
The violent movements of the worms placed in 
solutions of oxysantonin indicated that it would
- 1 0 -
be an excellent vermicide. This was confirmed 
by the following experiment#
An aspirator bottle was connected to a 
piece of glass tubing about 75 cm. long and so arranged 
that the open end of the tubing was higher than the 
outlet tube of the aspirator bottle. Forty cc.
of water was poured into the bottle, partially 
filling the glass tubing. A large earthworm was 
then placed in the bottle and, after ascertaining 
that the worm would not attempt to pass through the 
outlet tube, 1 0 cc. of the 0 .1 % solution of oxy­
santonin was added. After some agitation, the head 
end of the worm (in 3 out of 4 cases) sought and 
passed through the outlet tube into the glass tubing 
connected to it. The head end of the fourth worm 
appeared to seek the outlet tube but finally the 
tail end passed through into the glass tubing*
- 1 1 -
Table I
Stock BB solution: 1% NaHC0 3 t 0.04% Bile Salts. Concentration in
Percent of Stock Solution.
Elapsed 
Time 
(hrs. ) 1 0 0 6 6 . 6  33.3 10 Water




active pressed hut 
move on <PM
appear de­
pressed hut active 
move on




1 1 dead 
4 responded
Z move actively 6 show
normal move­
ments.




3 respond feebly 3 respond 




4 respond 1 shows 
to . sluggish 
response 
to <PF •
3 do not respond 
to @ hut move 1 dead 
spontaneously 
on return to 
solution.
Z dead.
- 1 2 -
Table II
S-oxysantonin Stock Solution: O.l^Oxys., 1^ HaH*Cog
0.04% Bile Salts.
Concentration in Percent of Oxysantonin 
Stock Solution
Blapsed
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6 move feebly, 
show little 




but move on moving, active 
agitation but slowly, 
of container
1 0 hours 1 0 dead 1 0 dead 8 responded 1 2 responded 14 
to 4 V to respond
normally
7 dead 4 dead 1 reaptssluggishly
to <f>F
II 2. Influence on Cardiac Rate, Amplitude of Contraction, 
________ and O u t p u t ___________________________________________
The influence on cardiac rate, force, and
output was determined on the frog heart* The method
employed was essentially the same as that described
33by Sollmann and Barlow « A Y-cannula which was 
provided with a wash-out side arm and with a tube 
for measuring the perfusion pressure was connected 
to two special Mariotte bottles containing iso­
artemisin in Howell-Ringer solution (80 mgm* per 1.), 
and Howell-Ringer solution, respectively* The 
Mariotte bottles were provided with glass tubes 
for the maintenance of constant pressure and for
aeration of the fluid*
After removing the ventral abdominal wall and
pectoral girdle of a pithed frog, the pericardium
was cut away from the heart and the plica v. bulbi post.
severed from the base of the ventricle. The Y-cannula
was inserted and tied into the inferior vena cava at
the point of junction of the two hepatic veins with
it* The height of the Mariotte bottles was adjusted
until the perfusion pressure was 15 mm., which was
sufficient to properly fill the heart. The right
aorta was ligated as close to the heart as possible
and an outflow cannula was tied into the left aorta,
also close to the bifurcation of the aorta in order
-14-
to avoid loss of fluid through any of the tranches# 
Both cannulae were fixed in position "by means of 
pins. The perfusate was collected in a 50 cc. 
graduated cylinder. The heart was connected to 
a recording lever hy means of a thread tied to the 
apex of the ventricle. Howell-Ringer solution 
was dropped on the surface of the heart to prevent 
drying.
After making a normal tracing of the heart 
and observing the output per 5 minutes while per­
fusing Howell-Ringer solution, the saturated solution 
of isoartemisin was perfused and observations at 
appropriate intervals were recorded, as shown by 
the tracings (Ho. 1 to 10) and tables III, IV, V, 
and VI. Control experiments were performed in 
which only Howell-Ringer solution was perfused.
Although there was occasionally an initial 
decrease in amplitude and an irregularity of con­
traction when the drug was perfused, the heart beat 
soon returned to normal. There was a continuous 
decrease in output in both the control and the 
isoartemisin experiments. In conclusion, it may 
be stated that S-oxysantonin does not signifieantly 





Control 15 minutes SO minutes Change Per Cent Change
rate amp* rate amp. rate amp. rate amp. rate amp.
(6 ) 52 59 57 26 54 26 2 -3 3.8 -1 0 .
(7) 52 25 52 25 52 27 0 2 0 8 . 0
(8 ) 57 15 62 1 2 60 1 2 S -3 5.3 2 0
(9) 52 17 51 16 62 1 2 1 0 - 5 19 29




15 minutes 30 minutes Change Per Cent iChange
rate amp. rate amp. rate amp. rate amp. rate amp.
(1)38 31 34 30 32 28 - 6  -3 -16 -9.
(2)52 2 1 42 17 42 17 iorH1 -19 -14
(3)50 2 2 48 2 2 51 2 0 1 - 2 2 . 0 -9.
(4)46 17 48 15 48 15 2 - 2 4.4 - 1 2
(5)46 16 50 14 51 14 5 -2 1 1 - 1 2
R e c o ra t 7.
R e c o rd / &.
R e c o rd / 9.
Re core/ /O.
re ^ fu s io n  o f  F ro q  H e a t /  
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Howell-Ringer Perfusion in cc. per 6 minutes.
Control 16 min. (app} 50 min. (app.) Per Cent. 45 min.
rate rate rate change change rate
(6 ) 11.7 12.5 1 1 . 8  plus 0 . 1 0.854 1 0 . 0
(7) 25*8 21.5 H 00 . 0 1 . 00 30.2 16.8
(8 ) 18.8 2 0 . 6 16.1 - 2.7 14.4 10.3
(9) 16.7 16.9 16.4 - 0.5 1 . 1 1 16.2
(1 0 ) 27.0 25.1 18.3 - 8.7 32.2 15.9
Table VI











(1 ) 15.6 8.3 -5.3 5.2 - 8.4 61.8 --
(2 ) 20.4 4.5 -15.9 6.1 -14.3 70.0 —
(3) 27.0 24.0 -3.0 23.2 - 3.8 14.1 18.2
(4) 16.8 15.2 -1 . 6  1 0 . 8 - 6 . 0 35.7 8.7
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II 3. Effect on Peripheral Circulation:-
The technique employed for perfusion of frog legs
34was that devised by A. Laewen and improved by P.
35Trendelenburg • Instead of injecting the drug 
solution into the perfusion cannula, however, it 
was thought preferable to use a Y-cannula and perfuse 
the saturated solution of isoartemisin (80 mgm. per 1.) 
and the Howell-Ringer solution separately from Mariotte 
bottles. The perfusion pressure of 150 mm. was kept 
constant by adjusting the glass tubes in the Mariotte 
bottles to the same level. The rate of perfusion 
was determined indirectly every two minutes by finding 
the time required for twenty drops to be delivered 
from the cannula tied in the median abdominal vein.
The perfusate was collected in a 50 cc. graduated 
cylinder and the amount recorded.
As will be seen on the graphs (1 to 11) and table 
(No.VII.) perfusion of isoartemisin caused a 
variable increase in rate in all but two eases. It 
is believed that in these two cases not enough time 
was allowed for the rate of perfusion of the Howell- 
Ringer solution to become approximately constant.
This is indicated by the sudden decrease in rate on 
returning from the drug solution to Howell-Ringer 
solution. No entirely satisfactory explanation
-24-
can be offered for the variable increase in rate of 
perfusion obtained with the 0*008% isoartemisin 
solution* It is possibly due to the variable extent 
of the edema present. The swelling is certainly an 
objectionable feature of the experiment and tends to 
obscure the results.
The vasodilator action of isoartemisin is a
property of santonin which has not been modified by
36oxidation. S* Bertino has shown that 1:5000 to 
1:10000 solutions of santonin have a marked dilator 
action on the blood vessels of the frog when tested 
by the Laewen-Trendelenburg method. He also reports 
a further dilation on reperfusing Ringer's soltition 
after santonin. This was not observed after per­
fusing with isoartemisin.
-25-
Tafcle VII,Exp. 1, 2 and 3
Time Sec./ Dropsy
Hr.Min. 20 drops min.
R 4 22 o•H 29.3
24 41.2 29.2
















6 00 57.0 21.0
2 54.0 22.2





R 14 58.6 20.5
16 59.6 20.2
18 59.2 20.3
Time Sec./ Drops/ 
Hr.Min.20 drops min.
3 42 36.4 33.0
46 38.8 30.9








































- 2 6 -
lime Sec. / DropB/
Hr.Min. 20 drops min.
3 42 65*0 18.5
44 65.4 18*3








4 16 98.2 12.2
18 103.2 11.6
22 78.6 15.3









R 44 86.8 14.0
46 88.0 13.6
48 ■ 88.4 13.6
Table IV, Exp* 4, 5 and 6.
'ime Sec./ Drops/ Time Sec! • / Drops/ Time Sec./ Drops,Hr.Min. 20 drops min. Hr.:Min.20 drops min. Hr.:Min •20 drops min
12 00 88.2 13.6 12 24 40.8 29.4 42 32.8 36.6
R 2 90.2 13.3 R 26 44.0 27.3 E 44 32.8 36.6
4 91.6 13.1 28 45.6 26.4 46 35.5 33.8
30 46.6 25.8 48 36.4 33.0
6 88.0 13.6 32 47.5 25.3 52 38.6 31.1
D 8 85.2 14.1 34 49.0 24.5 54 39.0 30.8
10 84.6 14.2 36 50.4 23.8 56 39.2 30.6
12 85.0 14.1 38 53.0 22.6
14 85.2 14.1 40 53.7 22.4 58 39.8 30.2
16 84.8 14.2 42 56.4 21.3 10 00 40.0 30.0
18 84.8 14.2 44 55.0 21.8 D 2 41.6 28.9
46 56.0 21.4 4 42.2 28.5
20 96.6 12.4 D 45 52.4 6 43.2 27.8
H 22 101.0 11.9 50 52.6 22.8
24 103.4 11.6 52 51.6 23.3 8 46.2 26.0
26 107.6 11.2 54 S3.0 22.6 E 10 48.2 24.9
56 52.2 23.0 12 49.1 24.4
28 87.2 13.8 58 53.0 22.6 14 49.6 24.2
D 30 7 5.0 16.0 1 00 52.3 23.0 16 51.6 23.3
32 72.6 16.6 2 52*3 23.0
34 73.2 16.4 20 46.2 26.0
36 72.4 16.6 4 57.9 20.7 D 22 43.4 27.6
38 73.8 16.3 E 6 59.2 20.3 24 44.4 27.0
40 75.6 15.9 8 60.1 20.0 26 45.2 26.6
42 75.4 15.9 10 63.6 18.9
44 76.7 15.7 12 62.0 19.4 28 49.4 24.3
46 76.8 15.6 14 63.2 19.0 R 30 51.2 23.4
48 78.2 15.4 32 51.9 23.1
50 79.2 15.2
52 80.0 15.0 34 49.4 24.3
D 36 48.8 24.6
54 93.4 12.9 38 49.2 24.4
R 56 94.0 12.8 40 49.6 24.2
58 93.8 12.8 42 41.4 29.0
1 00 95.4 12.6 44 41.2 29.1
2 94.2 12.7 46 41.8 28.7
4 92.6 13.0 48 42.6 28.2
6 92.6 13.0
10 92.6 13.0 50 46.0 26.1
R 52 47.3 25.4
14 85.2 14.1 54 47.8 25.1












Table VII,Exp. 7 and 8
Time See • / Drops/ Time Sec./ Drops/ Time Sec. / Drops
Hr. ••H 20 drops min. Hr .Min. 20 drops min. Hr. Min. 20 drops min,
1 54 39.2 30.6 3 32 46.9 25.5 10 06 66.3 18.1
R 56 40.7 29.5 D 34 46.3 25.9 R 8 65.8 18.2
56 41.2 29.2 36 45.4 26.4 10 66.2 18.2
2 02 43.2 27.8 38 45.9 26.1
4 45.4 26.4 40 46.0 26*1 12 62.0 19.4
6 45.2 26.6 44 46.0 26.1 D 14 59.0 20.4
8 45.6 26.4 48 38.6 31.1 16 55.2 21.7
50 37.6 31.9 18 53.9 22.2
10 43.6 26.8 52 36.0 32.3 20 52.7 22.8
D 12 43.8 27.4 54 35.8 33.5 22 53.2 22.6
14 43.6 27.6 56 35.8 33.5 24 54.9 21.9
16 41.8 28.7 58 35,8 33.5 26 53.0 22.7
18 42.0 28.6 4 00 34.4 34.9 28 52.9 22.7
20 42.2 28.5 2 32.6 36.8 30 55.3 21.7
22 42.4 28.3 4 31.5 38.1
24 41.0 29.3 6 31.6 38.0 32 56.0 21.4
26 40.6 29.6 8 31.2 38.5 R 34 57.9 20.7
28 41.8 28.7 10 30.8 38.9 36 58.2 20.6
30 41.6 28.-9 12 31.0 38.7 38 58.0 20,7
14 31.6 38.0 40 58.9 20.4
32 43.4 27.6 16 31.4 38.2 42 60.2 19.9
R 34 44.7 26.9 18 31.8 37.7 44 61.5 19.5
36 45.1 26.6 46 72.5 16.6
38 44.8 26.8 20 35.2 34.1 48 73.0 16.4
40 46.0 26.1 R 22 36.4 33.0 50 74.2 16.2
42 46.6 25.8 24 37.2 32.3
44 47.2 25.5 26 37.6 31.9 52 72.0 16.7
46 46.4 25.9 28 38.6 31.1 D 54 71.2 16.8
46 46.2 26.0 30 38.8 30.9 56 71.2 16.8
32 39.8 30.2 58 68.8 17.4
50 45.1 26.6 34 39.9 30.1 11 00 70.6 17.0
D 52 44.4 27.0 36 40.4 29.7 2 71.0 16.9
54 43.4 27.6 38 40.6 29 • 6 4 70.8 17.0
3 00 45.2 26.6 40 42.0 28.6 6 71.3 16.8
2 44.8 26.8 42 42.2 28.4 8 71.6 16.84 44.8 26.8 10 71.2 16.9
6 47.5 25.3 12 75.0 16.0
R 8 47.6 25.3 R 14 75.6 15.9
10 46.8 25.6 16 77.2 15.6
12 46.8 25.6 18 77.8 15.4
14 48.0 25.0 20 79.8 15.0





















































Hr. Min. 20 drops min.
11 40 50.8 23.6








D 58 50.8 23.6
12 00 51.8 23.2
2 67.4 17.8
R 4 67.2 17.9
-  2 9 -
Table VII,Exp. 10 and 11
ime Sec • / Drops/ Time Sec • / Drops/
Hr* Min. 20 drops min. Hr. Min. 20 drops min.
1 56 35.6 33.7 2 40 52.4 22.9
58 36.0 33.4 R 42 56.3 21.3
2 00 36.4 33.0 44 55.2 21.8
2 37.2 32.3 52 58.6 21.5
4 38.6 31.1 58 64.9- 18.5
6 39.6 30.3 3 00 67.4 17.8
8 39.8 30.2 2 66.2 17.6
4 67.8 17.7
10 36.1 33.3
12 36.7 32.7 8 50.0 24.0
14 37.4 32.1 D 10 49.4 24.3
16 37.2 32.3 12 48.7 24.7
18 37.4 32.1 14 49.1 24.5
16 49.8 24.1
20 41.6 28.9 18 50.6 23.7
22 42.1 28.6 20 51.2 23. 5
24 42.8 28.0
28 42.3 28.4 22 60.6 19.8
SO 42.8 28.0 R 24 64.2 18.7
26 67.2 17.9
32 39.9 30.1 28 70.2 17.1
34 40.2 29.9 30 71.8 16.7
36 40.6 29.6 44 72.0 16.7
38 41.0 29.3
40 41.6 28.9 46 67.8 17.7
D 48 69.0 17.4
42 44.9 26.7 50 72.0 16.7
44 52.6 22.8
46 52.4 22.9 52 85.2 14.1
48 52.3 22.9 R 54 88.2 13.6














Rate of Perfusion (drops/min.)
Experiment Ringerfs S. S. of Change Per Cent
No. -Oxysantanin in rate change
in RingerTs (drops/ in rate
___________________________________________________min. )__________
1 a 29.3 29.2 -0.1
b 21.0 22.8 1.8 8.6
2 a 20.8 22.9 2.1 10.1
b 19.4 21.0 1.6 8.2
3 a 15.8 21.2 5.4 34.2
b 11.6 15.8 • 4.2 36.2
4 a 13.1 14.2 1.1 8.4
b 11,2 16.6 5.4 48.2
c 13.0 17.4 4.4 33.8
5 a 21.4 23.3 1.9 CD .
6 a 30.6 30.2 -0.4
b 23.3 27.0 3.7 15.9
c 23.1 29.1 6.0 26.0
7 a 26.4 29.6 3.2 12.1
b 26.0 27.6 1.6 6.2
c 24.5 38.9 14.4 58.8
8 a 18.2 22.8 4.6 25.3
b 16.2 17.4 1.2 7.4
9 a 30.2 35.9 5.7 18.9
b 25.7 33.9 8.2 31.9
c 18.8 23.8 5.0 26.6
10 a 30.2 33.3 3.1 10.3
b 28.0 30.1 2.1 7.5
c 22.8 25.5 2.7 11.8
11 a 17.7 24.7 7.0 39.6
b 16.7 17.7 1.0 6.0
II 4. Ability to Act as a Diuretic;-
Diuresis has frequently been observed after
20 21 22the oral administration of santonin * *
22Knipping and Seel reported a 10% - 20% increase 
in the volume of urine excreted after the drug 
was ingested by humans and rabbits* The diuresis 
began in -jt hour and lasted for 24 hours*
It had been observed in the first group 
of experiments that the urine volume was greater 
after administration of S-oxysantonin than in the 
untreated animals* Consequently the amount of 
urine excreted was measured in the cases of 
animals (11) and (12)*
The increase was found to be especially 
marked during the second day of fasting* The 
increased urine output may be caused by injury 
of the kidney tubules*
- 3 2 -
Protocol #1 - Oxysantomin Diuresis:-
Rabbit #11.
Date Urine Volume Remarks
3/SO - 3/31 26
3/31 - 4/1 ’ 29
4/1 - 4/2 235
4/2 - 4/3 26
4/3 - 4/6 245
4/6 - 4/7 27
4/7 - 4/8 22
4/8 -4/9 23
4/9 - 4/11 425
4/11 - 4/14 74
4/14 - 4/15 170
4/15 - 4/16 57
4/16 - 4/17 17
4/17 - 4/18 43
4/18 - 4/20 79
4/20 -4/21 4
4/21 - 4/22 385
4/22 - 4/25 240
4/25 - 4/27 275
4/27 - 4/28 185
4/28 - 5/2 175
5/2 - 5/4 145
First day of fasting.
Second day of fasting.
Animal fed#
Animal fasted 4/5 and 6 
Oxys. adm. B.S. determined. 
Animal fed. Urine pH-6 
Sugar neg. to Fehling's.
Fasted 9-11.
Fed. Urine evap. in vac.
Fasted. B.S. determined.
Oxys. adm.
Fed. Urine orange-red in color.
Fasted 24 hours. B.S.O*
Fed. Food withdrawn from cage 
at 9 A.M. on 4/20.
Gage contained no feces.
Fed 4/23 after B.S*
Food removed at 12 noon 4/25.
Fed after B.S. at 10 A.M. 4/28. 
Fed. Food withdrawn at noon 5/2.
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Protocol #2 - Oxysantonin Diuresis
Rabbit #12.
Date Urine Volume Remarks
4/9 to 4/11 210
4/11 to 4/14 115
4/14 to 4/15 350
4/15 to 4/16 20
4/16 to 4/17
4/17 to 4/18 100
4/18 to 4/20 41
4/20 to 4/21 110
4/21 to 4/22 390
4/22 to 4/25 210
4/25 to 4/27 205
4/27 to 4/28 115
4/28 to 5/2 240








Some lost. Fasted 24 hours 
B.S.O*
Fed* Food withdrawn from 
cage at 9 A.M. on 4 /2 0  
Urine had extremely large 
amount of ppt. in it*
Fed 4/23 after B*S#
Food removed IE noon 4/25*
Fed after B.S. at 10 A*M* 4/28. 
Fed. Food withdrawn at 
noon 5/2.
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II 5. Ability to Lower the Blood-Sugar Level:-
A search of the literature for a basis 
for a pharmacological classification of drugs 
(other than insulin) which lower blood sugar 
indicates that most of these substances cause 
increased glycogen deposition in the liver by 
direct or reflex stimulation of the parasym­
pathetic nervous system. Many of the reflex 
stimulants also produce degenerative changes in 
the liver. The more important of these drugs 
have been listed in table IX. On the whole, 
the results obtained by use of these substances 
have been rather disappointing, both experiment­
ally and clinically. Such effects which have 
been obtained depend on their ability to
50stimulate the remaining healthy islet tissue
The role played by the vagus in blood-
sugar regulation has been the subject of much
51experimental work. de Corral obtained a 
small decrease in blood-sugar level within an 
hour in five out of eight experiments in which 
the right vagus of anesthetized dogs was stimu­
lated after section of the hepatic plexus.
52McCormick and co-workers stimulated the right
— 3 5—
vagus electrically at the oesophageal end of the 
stomach of anesthetized dogs and of decerebrated 
cats. A prompt fall was noted in one experiment
and' a less decided fall in four other experiments.
53Britton anesthetized cats with barbituric acid 
and cut the branches of the right vagus to the 
stomach and upper intestine, sectioned the hepatic 
plexus as a rule, and removed the left adrenal or 
cut its nerve supply. Several hours after the 
operation was performed, he stimulated the right 
vagus at the oesophageal end of the stomach for 
a period of one to two hours. He obtained a fall 
of blood sugar of 18 mgm* per hour in eleven 
experiments in which the hepatic nerves were cut 
and a fall of 27 mgm. per hour in six experiments 
in which the hepatic nerves were intact. No effect 
was produced on the blood-sugar level if the blood 
vessels and nerves of the pancreas were tied off 
before stimulation. Britton concluded that impulses 
to the islet tissue through the vagus might come into 
play only when hormonic regulation was inadequate to 
maintain the normal blood-sugar level or as an
emergency measure.
54 55la Barre and Zunz and la Barre proved by
means of transfusion experiments the importance of 
the vagus mechanism in blood-sugar regulation.
Table IX.

















Gr. A* Clark showed in the rabbit that drugs 
which stimulate parasympathetic nerve endings caused 
lowering of blood-sugar level but usually failed to do 
so after section of the right vagus. After section of 
the right vagus below the cardiac branches, the blood 
sugar fell almost immediately* The tolerance for 
glucose on injection of 1 Cm. per kilo, was not decreased 
but the blood sugar returned to the normal level more 
rapidly than before vagotomy. After two months, however, 
this condition was reversed: hyperglycemia lasted con­
siderably longer than in the normal. Clark stated that 
the regulatory fibers of the vagus appear to be of two
kinds: tonic inhibitory and secretory*
57Quigley et al. reported only that the ability
of double vagotomized dogs to remove glucose from the
circulation was greater than that of the controls. The
tests were performed two weeks after the operation.
47Santonoise and co-workers extracted and
purified a solution of a substance, vagotonine, from the
pancreas which he believed to be the hormone which caused
glycogen storage in the liver. He found, clinically, that
the dosage of insulin could be greatly reduced in favorable
cases if it were supplemented by injections of vagotonine.
The hypoglycemic action of santonin has been
studied both experimentally and clinically. Extremely
58variable results have been reported. Stasiak adminstered
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daily doses of 0.2 Gm. to 0.4 Gm. of the sodium salt in 
aqueous or oily suspension by stomach tube to rabbits 
over a period of about three weeks. The animals were 
fasted for 10 to 15 hours before each injection. No 
change in blood-sugar level occurred at first but at the 
end of this time hypotonicity, paresis, fits of convul­
sions of the extremities, lowering of body temperature, 
and hypoglycemia tin all but one case) resulted. The 
symptoms were relieved temporarily by the inj'ection of 
dextrose in all except the case in which there was no 
hypoglycemia. Death resulted when the administration 
of dextrose was discontinued. Degeneration of the liver 
and absence of liver glycogen were found in every case*
The kidneys showed small hemorrhagic spots and slight 
parenchymatous degeneration. The pancreases were normal* 
No sugar was found in the urine. He assumed that the 
disturbance of hepatic function was responsible for the
symptoms observed. This conclusion is supported by the
59work of Mann and Magoth on dogs which were totally 
hepatectomized by a special method. The same symptom 
complex was observed within an hour after the final 
operation, which involved removal of the liver. In 
addition to a progressive fall of blood-sugar level, they 
noted an increase of uric acid in the blood, the appearance 
of bilirubin in the plasma and urine, and a fall of muscle 
glycogen to 50°/o of the normal. The symptoms disappeared 
temporarily and the muscle-glycogen-content rose to normal
on the injection of glucose.
Walterhbfer^° treated 8 diabetics with santonin 
in doses of 0.025 Gm. The time of treatment was 15 
days when one dose was given daily or 5 days when three 
doses were given daily. The drug was used in the form 
of Dr. Sejournet's pills^ , pure santonin, and the 
sodium salt. The urine sugar was sometimes reduced for 
a few days but then returned to the former level or higher. 
There was no reduction in amount of acetoacetic acid in 
the urine nor was there any improvement in carbohydrate 
tolerance. Blood sugar was not determined.
Leulier and Koche^ found that the injection of 
approximately 0.25 Gm. of santonin per kilo, arrested or 
decreased the glycosuria of phlorizinized rabbits without 
affecting the hyperglycemia. They formulated the hy­
pothesis that the antiglycosuric action was due to a 
raising of the renal threshold for glucose, accompanied 
by oliguria, and suggested that santonin might be a useful
adjuvant in the treatment of certain diabetics.
63Sei ichi Ishikawa reported that 0.05 to 0.1 Gm. of 
santonin per kilo, perorally caused no change in the blood- 
sugar level of rabbits, while 0.9 Gm. per kilo, caused a 
temporary hyperglycemia. Santonin had no effect on the 
hyperglycemia of adrenalin or glucose. Continued admin­
istration in man caused no change in blood-sugar level.
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Ijnro Fu;jiiS4and Bomer6  ̂proved experimentally that 
large doses of santonin cause an increase of blood sugar 
and lactic acid independent of the convulsant effect* 
i’ujii demonstrated, in addition, that the hyperglycemia 
was independent of the effect on the respiratory center 
and on body temperature and that the alkali reserve was 
lowered*
In view of the above experimental and clinical 
results, the administration of santonin in diabetes 
would seem to be wholly undesirable*
The study of the action of 5-oxysantonin on the 
blood-sugar level of the rabbit was therefore undertaken 
to determine the effect of oxidation on the santonin 
molecule *
II 5-a. Ability to Lower the Blood-Sugar Level of
__________ Pasted Animals
Babbits were fasted for at least 48 hours and blood-
sugar estimations were made, using the recently developed
/■ n
Folin ferrieyanide method
A 0.1 cc* sample of blood is rendered protein-free 
by means of tungstic acid. Potassium ferrieyanide is 
reduced in a sodium cyanide-sodium carbonate medium by the 
reducing substances of the blood* Colloidal Prussian 
blue is formed by adding ferric iron in acacia and is 
compared colorimetrically with an appropriate standard 
which has been treated in the same manner.
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After the control determination, oxysantonin was 
administered by stomach tube. Samples were then taken 
after hour, 1 hour, 2 hours, 3 hours, 4 hours, and in 
some cases after 5 hours*
Neither small nor large doses of isoartemisin had 
any effect on the blood-sugar level within four to five 
hours. Animals (l), (2), (3), and (7) died during the 
night so that the data are necessarily incomplete in these 
cases. Blood-sugar determinations were made on rabbit (6) 
when the level was critically low* Test of the urine 
with Fehling's solution showed no reducing substance.
Three hours after the control level was determined, clonic 
convulsions set in with intervening periods of extreme 
muscular weakness. These convulsions were relieved by 
the intravenous administration of dextrose. The animal 
was fed after the blood sample for the next hour was taken. 
On the following morning a value of 112 mgm* per cent, 
was obtained. The animals treated with santonin by 
Stasiak, as well as those on which Mann and Magoth performed 
a total hepatectomy, reacted similarly.
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Table IX. Bloods Sugar Level after Administration of Isoartemisin
No. Date Wt.in Control hr. 1 hr. 2 hr s. 3 hrs. 4 hrs. 5 hrs. Remarks
and 1935 kilos. (c) Oxys. adm.
Sex by stomach
tube •
5/27 1.9 126 128 121 120 112 -- 100 0.1 Gm./
kilo.after c




7/9 1.71 106 124 119 124 119 —  —  0.18 Gm.
after c
7/10-11 —  -- —  —  —  —  -- 0.18 Gm. daity
7/12 106 104 105 -- —  111 —  0.18 Gm.
after c
7/13 —  —  —  —  —  —  —  0.18 Gm.
7/15 100 114 110 114 112 —  —  0.18 Gm.
after c
7/16-17 0.18 Gm.daily




7/22 1.70 106 108 110 107 112 109 —  0.18 Gm*
after c
7/23-24 0.18 Gm.daily
7/25 99 101 113 123 121 110 —  0.18 Gm.
after c
7/29 103 115 113 101 —  -- -- 0.18 Gm.daily
' 7/26,(27,28),
29 after c
8/1 107 98.5 100 103 99.0 90.9 —  0.18 Gm.after
c




------------------------------------------------- —  u  *  r trr /" \
Table IX# Blood-Sugar Level After Administration of Isoartemisin
No# Date Wt#in Control -I* hr. 1 hr. 2 hrs. 3 hrs# 4 hrs. 5 hrs* Remarks 




5/27 1.82 156 125 116 132 132 —  116 0.1 Gm./
y kilo after
îC c
^  5/29 1.82 124 125 122 124 124 -- 117 0*4 Gm./













6/20 2.37 104 132 115 123 142 123 0.18 Gm.
after c
7/8 2.4 101 110 114 112 110 107 1*2 Gm#/kilo 
after c






5/28 1.83 117 121 122 123 123 1 2 8 0*2 Gm./
kilo 
after c




Table IX. Blood-Sugar Level after Administration of Isoartemisin
No. Date Wt.in Control -J- hr. 1 hr. 2 hrs. 3 hrs. 4 hrs. 5 hrs. Remarks





5/00 1.8 100 129 127 125 129 —  107 1.2 Gm./
kilo (oil emuls.)
J * after c

































Table IX. BloocUSngar level After Administration of Isoartemisin
132 119
No. Date Wt.in Control 










7/8 2.S3 102 110 111 117
7/9-10-11










7/18 2.11 108 120 116 120
7/19
7/20













101 102 108 108
86.3 98.1 113 102




























































Table IX. Blood-Sugar level after Administration of Isoartemisin
No* Date Wt.in Control | lir, 1 hr* 2 hrs* 3 hrs. 4 hrs, 5 hrs. Remarks
and 1936 kilos, (c) Oxys* adm.
Sex by stomach
tube






4/11 1.6 109 137 137 126 —  —  —  1 3m. 0/
kilo
after c •
4/15 97 115 116 114 —  —  106 1 Sm.O/
kilo 
after c





4/El 101 —  —  -- -- —  103 Fasted
24 hrs#
4/22 106 -- —  —  —  —  -- Fasted
53 hrs#
4/23 106 -- —  —  -- —  —  Fasted
71 hrs#
4/28 108 -- -- -- -- —  —  Fasted
72 hrs*
5/5 118 —  —  -- —  -- Fasted
72 hrs#
















Date Wt. in Control % hr. 1 hr. 2hrs. 3hrs. 4 hrs. 5 hrs. Remarks 
1936 kilos. (c) Oxys. adm*
by stomaeh 
tube
4/11 1.58 98 121 120 114 1 G-m.O/ 
kilo 
after c
4/15 97 116 110 108 mt mm * * 101 1 Gm.O/ 
kilo 
after c
4/18 1.7 96 107 118 112 1 Cm. 0/ 
kilo 
after e
4/21 96 • 96 Fasted 24 hrs*
4/22 118 Fasted 
53 hrs.
4/23 112 Fasted 
71 hrs*
4/28 106 Fasted 
72 hrs.
5/5 107 Fasted 
72 hrs.










II 5b, Ability to Lower Blood-Sugar Level of Animals 
________ which had Received Dextrose;-__________________
Since no lowering of blood-sugar level was 
obtained on administration of &-oxysantonin by 
stomach tube to fasting rabbits, it was thought 
advisable to find whether isoartemisin would affect 
the alimentary hyperglycemia caused by the adminis­
tration of a 20% solution of dextrose in water*
Control experiments were performed in which 
4 Grm./kilo. of dextrose was given by stomach tube* 
Then 4 Grm./kilo. of dextrose and varying doses of 
S -oxysantonin were administered simultaneously.
The isoartemisin did not affect the blood-sugar 
level in alimentary hyperglycemia significantly. 
Bertino found that 0.15 Cm./kilo, of santonin 
when dissolved in ethylene glycol (3 cc./kilo.) 
and administered to rabbits intramuscularly produced 
an exaltation after 1 hour of the hyperglycemia 
caused by the oral administration of 6 Om./kilo. 
of dextrose. He did not observe a significant 
increase after 0.01 Cm./kilo, of santonin and 3 Cm./ 
kilo, of dextrose.
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Table X. Blood-Sugar Level after Isoartemisin and Glucose
Ho. ©ate Wt.in Control hr. 1 hr. 2 hrs. 5 hrs. 4 hrs. Remarks,
and 1955 kilos. (c) Oxys. adm.
Sex by stomach
tube.
7/19 1.4 108 110 116 110 115 116 Control exp.
Q 10 cc. water
given by 
s.t. after c
7/25 1.48 158 189 194 164 185 144 4 Gm. dextrose/!
kilo after e iI
7/26 107 205 222 205 164 115 (4 Gm.dextrose/!
(after c 
(0*1 Gm.Oxys/ i 
kilo
8/2 115 170 180 170 115 110 (4 Gm. dextrose/
kilo after c ■ 
(0*2 Gm. Oxys/ 
kilo
8/21 1.70 119 250 248 210 155 110 (4 Gm.dextrose/
kilo after c 




7/19 1.96 100 106 109 109 115 112 Control exp.
10 ce. water 
given in s.t. 
after e
7/25 2.08 128 187 198 162 . 154 150 4 Gm. dextrose/
kilo after c




8/2 100 175 196 179 142 122 4 Gm. dextrose/
kilo after c 
0.2 Gm. Oxys/ kilo '
8/21 2.15 114 197 251 208 192 107 4 Gm. dextrose/




II 6a. Toxicity and Pathological Effects Produced on Liver and 
________ Kidney of Rabbits:-_____________________ ________________
Orally administered doses of 0*4 Cm. per kilo* of 
oxysantonin were given to rabbits twice, 1 Cm./ kilo, 
nine times, and 1*2 Cm./kilo. given three times without 
appearance of convulsions or significant change of blood- 
sugar level within five hours. Santonin, on the other
hand, is a eonvulsant poison when 0*5 Cm./kilo, is given
31by stomach to the rabbit • The insolubility of the 
compound may, however, have prevented the appearance of 
acute toxic effects. Convulsions with hypoglycemia 
were noted in the case of rabbit (6) 21 days after the 
administration of 1*2 Oms. of the drug per kilo, of body 
weight.
The livers and kidneys of rabbits (1), (2), (3), 
(6), (7), and (8) were examined histologically by 
Dr. C. Gr* Warner. Advanced degenerative changes were 
found in the livers of (1), (2), and (8) and in the 
tubules of kidneys (1), (3), (6), and (7). One plus 
degeneration was observed in the remaining organs. The 
following report was submitted:
RABBIT #1: Liver 92 Oms.
Two sections from liver, both 
show advanced degenerative changes in 
the liver cells. This is generalized 
and evenly distributed throughout the 
liver, without regard to lobular zone 
or periphery or central part of liver.
Not only is the cytoplasm granular and 
vacuolated but there is picnosis and
- 51-
KIDNEY:
nuclear destruction. At least 10% 
of the cells are disintegrated. In 
a comparative way this liver represents 
4 plus degeneration,
A section from the Kidney shows about 
two plus degeneration of the convoluted 
tubules only.
RABBIT #11: Liver 61 Gms,
Degeneration in this organ is three 
plus with some pigmentation and nuclear 
destruction, 5 to 10%. The degeneration 
in this section is more pronounced about 
the central zone.
KIDNEY: Shows one plus tubular degeneration#
RABBIT #111: liver 42 Sms.
Section of liver shows marked congestion 
but less than one plus degeneration. There 
are practically no degenerative nuclear 
changes. The kidney shows three plus 
tubular degeneration.
RABBIT #VI: Liver 40 Sms.
Liver shows one plus degeneration, which 
is more marked about the central vein zone. 
Tubular epithelium in the kidney is degen­
erated to the extent of two plus#
RABBIT #VII: Liver 56 Oms.
One plus degeneration liver cells which 
is slightly more evident in the central 
zone, with pigmentation and slight nuclear 
degeneration.
KIDNEY: Shows three plus tubular changes.
RABBIT #VIII; This liver fixed in formalin immediately 
after death to serve as a control for auto­
lysis, shows extensive degeneration which 
must have been ante-mortem. Four plus cyto­
plasmic changes are present with 25 to 50% 
nuclear degeneration. Incidentally there 
are two other apparently unrelated lesions, 
Tuberculosis and Adenoma.
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IIA. 6b. Toxicity to Salamanders
Ten animals each were placed in 400 cc. of 
water in one liter beakers marked (0) and (S), 
respectively. Two salamanders in beaker (C) 
served as controls. Those in (0) were treated 
from time to time with oxysantonin while the 
animals in (S) were treated with equal amounts 
of santonin per animal. Observations were made 
on their appearance, activity, and heart rate, 
as noted in protocol 3. Only slight differences 
were observed when small doses of the respective 
drugs were administered. With larger doses, the 
animals in (S) became hyperirritable and excreted 
large amounts of fecal matter. Those in (0) did 
not appear to be more active than the controls 
and excreted less matter than those in (S). After 
prolonged treatment, muscular weakness and loss of 
equilibrium were much more pronounced in the animals 
which were treated with isoartemisin. No significant 
changes in heart rate were observed. Santonin 















10 mgm. of oxysantonin added to (0)
10 mgm, of santonin added to (S)
(0): 3 animals appear weak and float near surface
(S): No observable difference from (C)
All inactive
Water changed and 10 mgm. of drug added to respective 
beakers. Show some activity after 5 minutes#
All appear normal
(S): 1 salamander found dead. Heart rates determined 
before and 1^ hours after changing water. All 
animals fed with Tubafex worms.
Hef5t HearfofaSifst13 1 6 -S °
(S) 30-35/min. (S) 30*32
(C) 28-32/min. (C) 27-30
10 mgm. drug added to fresh water in respective beakers
(S): All but one animal floating near surface. When
disturbed appear very weak. Water very cloudy, 
possibly from dead Tubafex.
(0): Two animals floating near surface; one very
weak. Dead Tubafex in ball on bottom of beaker. 
fC): Both animals on bottom of beaker. Swim actively
when disturbed.
Water changed immediately. Slimy deposit on walls 
of (S) removed. All recover after changing water.
When first observed, all animals were on the bottoms 
of the beakers, later in the day, 1 salamander in 
(S) was found dead. Water changed in all beakers 
every 2 or 3 days until 12/17/35.
Water changed. 10 mgm. drug added to respective 
beakers. No immediate symptoms.
Water changed in all beakers every 3 or 4 days until 
1/8/36
Heart ^g^eg^ (^averages) at 19.4°
(S) 42/min.
(0) 42/min.








(S): Animals hyperirritable. Large amounts of feoal
matter in beaker.
(0): Animals appear normal. Smaller amounts of fecal
matter present*
(C): No change.
(S); Animals still somewhat hyperirritable*
(0): No change.
(C ): No change.
Heart ^ 5 t S4^m?na^eS ̂
(S) 43/min.
(C) 40/min.
Water changed in all beakers*
SB mgm. of santonin added to (S)
40 mgm. of oxysantonin added to (0)
(S): Animals appear greatly agitated. Swim about
rapidly,and go to surface of water, apparently for air* 
(0): Less marked but similar reaction took place later.
(0): Two animals found dead. Three others apparently 
suffering from anoxemia and very weak. Grills of all 
animals fluffed. Animals recover on oxygenating 
solution. Did not show hyperirritability. Beaker 
very dirty.
(3); Animals hyperirritable. Bise occasionally to 
surface and appear to swallow air*
(G ): No change.




Tubafex put in beakers. Only controls eat.
Water changed and Tubafex added to each beaker*
(0): Two animals die during njght*
(S): Animals no longer hyperirritable.
On feeding with Tubafex, animals in (G) and (S) eat 
readily. Those in (0) show little desire to eat.




















24 mgm. of oxysantonin added to (0)
32 mgm. of santonin added to (S)
(0): One animal very weak. No hyperirritability
observed.
(S): Animals "start" on tapping beaker*
Water changed in all beakers 
24 mgm. of oxysantonin added to (0)
32 mgm. of santonin added to (S)
(0): Three animals very weak. Have difficulty in
maintaining normal position.
(S): No apparent change.
Water changed. Tubafex fed. Only control shows desire 
to eat.
He ar f ^atgg aJ^17.6°
(S) 36/min.
(C) 31/min.
30 mgm. of oxysantonin added to (0)
40 mgm. of santonin added to (3)
(S): 6 animals dead. 1 very weak.
(0): 3 animals very weak. Have difficulty in
maintaining normal position*
Water changed in all beakers#
(0): 2 animals dead.
Water changed in all beakers.
(0): 1 animal dead. Others weak.







All animals sacrificed for histological examination.
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IIA. 7. Excretion and Fate:-
The urine of rabbits which had been fed oxy­
santonin was collected and reduced to a light brown 
mass by distillation in vacuo. This residue was 
extracted with boiling alcohol and the process was 
repeated until a small amount of brown oily residue 
remained. This oil was soluble in cold alcohol, 
ether, chloroform, and carbon tetrachloride and 
insoluble in water, acetone, and petroleum ether.
A small amount of gelatinous yellow precipitate was 
obtained by fractional precipitation of a solution 
of the oil in chloroform'by the addition of petroleum 
ether. The precipitate was soluble in cold alcohol.
The product was too impure and the amount of it 
was too small to attempt an analysis.
IIB. 1. Ability of Santoninamine to lower the Blood-Sugar Level 
_________ of Fasted Animals:-___________________ _________________ _
Doses of 0.5 G-m./kilo. of the sulfate of 
santoninamine were given to four animals which had 
been fasted for 18 hours. In three out of four cases 
a pronounced lowering of blood-sugar level was observed. 
In the fourth ease, the last determination made showed 
an unusually high blood-sugar level. Since no 
immediate effects were noted after the administration, it 
was concluded that the lowering was due to a toxic action 








70.71 72 72 74 75guanidine , synthalin * ’ , and neosynthalin .
The urine of rabbits which had received injections 
of santoninamine reduced Fehling's solution# No
reduction was observed when the urine was tested before 
the injection of this drug*
Table XI. Effect of Santoninamine oifi Blood-Sugar Level
Date Wt.in Control -J- hr# 1 hr. 2 hrs# 5 hrs. Remarks




5/5 1.42 98.3 98.6 100 94.4 95.3 0.5 Cm.Samine/
kilo, after c 
Fasted 18 hrs.
5/6 74.2 -- —  -- -- Fasted 42 hrs.
44.2 -- -- -- Fasted 52 hrs.
5/7 -- -- —  -- -- Found dead.
No gas dis­
tension.
5/6 1.55 110 113 110 106 81.7 0.5 Cm. Samine/
kilo, after c 
Fasted 18 hrs.
5/7 91.2 —  —  115 Fasted 44 hrs.
5/8 191 -- —  184 Fasted 67 hrs.
Animal very 
irritable.








Table XI* Effect of Santoninamine on Blood-Sugar Level
No. Date Wt.in Control ^ hr* 1 hr. 2 hrs. 5 hrs. Remarks
and 1936 kilos. (e) Sulfate of
Sex Samine adm.
by subcut. inj.
5/7 1.63 103 105 104 93.5 —  0.5 Gm. Samine/
I* kilo.after c.
lasted 18 hrs.
5/8 76.1 —  -- 81.9 Fasted 38 hrs.
5/9 42.9 -- -- —  —  Fasted 62 hrs.
Animal
sacrificed.
6/7 1.54 93.4 104 106 97.2 —  0.5 Cm. Samine/
/£> kilo, after c.
Fasted 18 hrs.
6/8 100 —  —  —  109 0.5 Cm. Samine/
kilo, after 
last B.S. det’n. 
Fasted 38 hrs#
5/9 124- -- —  -- 124 Animal fed after
B.S.detTns.
5/11 113 —  -- -- 109 Animal had not
been fasted*





IIb« 2« Pathological Bffects Produced on Liver and Kidney:* 
Histological studies of the livers and kidneys 
of rabbits (13), (1$), (15), and (16) revealed little 
evidence of hepatic injury. There was marked con­
gestion and coagulation of the tissue surrounding 
the gall bladder, however. The kidneys showed 
slight to marked tubular degeneration.
The following report was submitted by Dr. Warner:
(13) Liver: There is rather marked con­
gestion and enlargement of the sinusoid 
throughout the section. The liver cells 
themselves appear slightly swollen but 
are well preserved. There is a coagu­
lation of the liver tissue surrounding 
the gall bladder.
(13) Kidney: Section shows an even, thin 
capsule. The convoluted tubular epi­
thelium appears pale and pink, gran­
ular cytoplasm.
(14) Liver: Sinusoidal congestion. Pallor 
and swelling of liver cells, most 
marked about the periphery of each 
lobule.
(14) Kidney: Marked tubular degeneration.
(15) Liver: No abnormal congestion. No 
apparent degeneration. Several focal 
areas of necrosis and inflammatory 
reaction (apparently parasitic disease).
(15) Kidney: Slight tubular degeneration.
(16) Liver: No congestion. No apparent 
degeneration.
(16) Kidney: Moderate tubular degeneration. 




A. Isoartemisin has the following pharmacological 
actions:
1* The vermieidal action is weaker than 
that of santonin. However, it is an 
excellent vermifuge.
2. Cardiac rate, amplitude of contraction, 
and output are not significantly affected 
on perfusing an0.008$ solution.
3. A slight hut significant dilating action
on the vessels of the frog leg was observed.
4. A marked diuresis was observed on the second 
day of fasting after administration of the 
drug.
5a, Ho effect was found on the blood-sugar 
level of fasting animals. In one animal 
a terminal hypoglycemia was recorded.
5b. The blood-sugar level in alimentary hyper­
glycemia was not significantly affected 
by the simultaneous administration of 
isoartemisin and dextrose.
6. Ho acute toxic effects were produced in 
either rabbits or salamanders. However, 
after prolonged administration the liver 
and kidneys showed marked degeneration in 
many cases.
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7* No S-oxysantonin was recovered from the 
urine, indicating that it was either 
excreted in very small amounts or had been 
altered chemically*
B-l. The subcutaneous administration of a 20% 
solution of the sulfate of santoninamine 
produced no immediate effect on the blood- 
sugar level of rabbits* A pronounced hypo­
glycemia occurred later in three out of 
four cases* In the fourth case the last 
blood-sugar estimation showed a marked rise*
2. Santoninamine produced slight to marked 
tubular degeneration of the kidney. No 




Isoartemisin is an excellent vermifuge and is 
devoid of the eonvulsant action of santonin. Toxic 
effects are not observed unless it is adminisiared over 
long periods and in relatively enormous doses. It has 
no significant effect on blood-sugar level.
The sulfate of santoninamine, like other amino 
derivatives, which have been used in treatment of 
diabetes, lowers blood-sugar level, possibly through a 
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